VJ

Vipulkumar Jayantilal Barot

Active Director Director DIN 07515636
DIN 07515636 First appointment May 2016 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Vipulkumar Jayantilal Barot

Data last updated:

Vipulkumar Jayantilal Barot is a Director at Verminus Pharma Private Limited (since 2016). The company operates in Business Services.

DIN 07515636
Primary Designation Director
Industry Business Services
First Appointment 11 May 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Verminus Pharma Private Limited U74999GJ2016PTC091915
Director11 May 20162016Active

Board colleagues of Vipulkumar Jayantilal Barot

Directorship timeline

Open interactive timeline →
Verminus Pharma Private Limited
Premium access

Shareholding and investment profile for Vipulkumar Jayantilal Barot

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vipulkumar Jayantilal Barot

Vipulkumar Jayantilal Barot currently holds 1 directorship: Verminus Pharma Private Limited (Director, since 11 May 2016).

Vipulkumar Jayantilal Barot was first appointed on 11 May 2016 as Director at Verminus Pharma Private Limited.

The current boards of Vipulkumar Jayantilal Barot's companies include Haresh Shamalbhai Patel (Verminus Pharma Private Limited), Sagarkumar Ishvarbhai Patel (Verminus Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available